Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Med. 2012 Sep;44(6):523-9. doi: 10.3109/07853890.2012.687833. Epub 2012 Jul 11.

Hereditary angioedema treatment options: the availability of new therapies.

Author information

1
Department of Dermatology and Venerology, Medical University of Graz, Graz, Austria. werner.aberer@medunigraz.at

Erratum in

  • Ann Med. 2012 Sep;44(6):529.

Abstract

Hereditary angioedema (HAE) is a potentially life-threatening autosomal dominant disease characterized by recurrent episodes of oedema, commonly occurring in the skin, abdomen, and upper respiratory tract. After many years during which limited treatment options were available, a range of newer therapies with proven efficacy have been approved in Europe by the European Commission for the treatment of HAE attacks. However, due to differing legislation and financial restrictions, these treatment options are not available in all countries. Home therapy and self-administration of treatment are recommended in order to minimize the burden of disease upon the patient, with the ideal treatment option being effective, well-tolerated, and easy to prepare and administer. Recently, the Hereditary Angioedema International Working Group (HAWK) consensus recommended early, on-demand treatment for HAE. This article reviews the current treatment options available, and considers the need for treatment guidelines to recommend the appropriate therapy.

PMID:
22784006
DOI:
10.3109/07853890.2012.687833
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center